Literature DB >> 31949812

Overexpression of miR-153 promotes oxidative stress in MPP+-induced PD model by negatively regulating the Nrf2/HO-1 signaling pathway.

Jianzhong Zhu1,2, Shan Wang2, Weiwei Qi3, Xue Xu3, Yingyin Liang3.   

Abstract

Increasing evidence points to oxidative stress as a chief mediator of Parkinson's disease (PD) characterized by progressive loss of dopamine neurons in the pars compacta of the substantia nigra. At present, microRNAs (miRNAs) have been recognized as important regulators in oxidative stress. Furthermore, miRNAs were also involved in the neuropathology of neurodegenerative disorders, including PD. In this study, we aimed to explore the influences of miR-153 and Nrf2 in oxidative stress during the development of PD. It was found that the expression of miR-13 and Nrf2 detected by qRT-PCR were significantly increased and decreased, respectively, in serum of PD patients and MPP+-induced SH-SY5Y cells. The target relationship between miR-153 and Nrf2 was determined by dual-luciferase assay. Moreover, after transfecting with miR-153 mimics and inhibitor, the expressions of Nrf2 in mRNA and protein were down-regulated and up-regulated, respectively. The indexes of oxidative stress were examined by biochemical methods. The data revealed that miR-153 could facilitate oxidative stress by negatively regulating Nrf2 in MPP+-treated SH-SY5Y cells. Finally, it was observed that miR-153 could suppress the Nrf2/HO-1 signaling pathway in MPP+-treated SH-SY5Y cells. Therefore, these findings indicated that overexpression of miR-153 could promote oxidative stress in PD by targeting the Nrf2/HO-1 signaling pathway, possibly providing a new way to treat PD. IJCEP
Copyright © 2018.

Entities:  

Keywords:  Parkinson’s disease (PD); microRNA-153 (miR-153); nuclear factor-E2-related factor 2 (Nrf2); oxidative stress

Year:  2018        PMID: 31949812

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  8 in total

Review 1.  MicroRNAs in the pathophysiology of Alzheimer's disease and Parkinson's disease: an overview.

Authors:  Mohammad Rafi Khezri; Keyvan Yousefi; Naime Majidi Zolbanin; Morteza Ghasemnejad-Berenji
Journal:  Mol Neurobiol       Date:  2022-01-09       Impact factor: 5.590

Review 2.  Parkinson's disease and microRNAs - Lessons from model organisms and human studies.

Authors:  Brian Evans; Howard A Furlong; Alexandre de Lencastre
Journal:  Exp Gerontol       Date:  2021-10-08       Impact factor: 4.032

3.  Apolipoprotein E Polymorphism and Oxidative Stress in Human Peripheral Blood Cells: Can Physical Activity Reactivate the Proteasome System through Epigenetic Mechanisms?

Authors:  Rebecca Piccarducci; Simona Daniele; Beatrice Polini; Sara Carpi; Lucia Chico; Jonathan Fusi; Filippo Baldacci; Gabriele Siciliano; Ubaldo Bonuccelli; Paola Nieri; Claudia Martini; Ferdinando Franzoni
Journal:  Oxid Med Cell Longev       Date:  2021-01-02       Impact factor: 6.543

4.  Effects of propofol on neuroblastoma cells via the HOTAIRM1/miR-519a-3p axis.

Authors:  Guan Wang; Yao Yu; Yang Wang
Journal:  Transl Neurosci       Date:  2022-03-10       Impact factor: 1.757

Review 5.  The Role of Non-Coding RNAs in the Pathogenesis of Parkinson's Disease: Recent Advancement.

Authors:  Hanwen Zhang; Longping Yao; Zijian Zheng; Sumeyye Koc; Guohui Lu
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-30

6.  Nrf2/HO-1 Signaling Stimulation through Acetyl-11-Keto-Beta-Boswellic Acid (AKBA) Provides Neuroprotection in Ethidium Bromide-Induced Experimental Model of Multiple Sclerosis.

Authors:  Shubham Upadhayay; Sidharth Mehan; Aradhana Prajapati; Pranshul Sethi; Manisha Suri; Ayat Zawawi; Majed N Almashjary; Shams Tabrez
Journal:  Genes (Basel)       Date:  2022-07-25       Impact factor: 4.141

Review 7.  The role of microRNAs in neurodegenerative diseases: a review.

Authors:  Zhixin Lei; Taolei Sun; Shijie Li
Journal:  Cell Biol Toxicol       Date:  2022-09-20       Impact factor: 6.819

Review 8.  Oxidative Stress-Responsive MicroRNAs in Heart Injury.

Authors:  Branislav Kura; Barbara Szeiffova Bacova; Barbora Kalocayova; Matus Sykora; Jan Slezak
Journal:  Int J Mol Sci       Date:  2020-01-05       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.